Effects of vitamin D level on survival in patients with hepatocellular carcinoma

por Bilgen, Ali, Kani, Haluk Tarik, Akdeniz, Esra, Alahdab, Yesim Ozen, Ozdogan, Osman, Gunduz, Feyza
Publicado 2020

SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells

por Poat, Bret, Hazari, Sidhartha, Chandra, Partha K., Gunduz, Feyza, Balart, Luis A., Alvarez, Xavier, Dash, Srikanta
Publicado 2010

Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication

por Poat, Bret, Hazari, Sidhartha, Chandra, Partha K, Gunduz, Feyza, Alvarez, Xavier, Balart, Luis A, Garry, Robert F, Dash, Srikanta
Publicado 2010

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis

por Ergenc, Ilkay, Gokcen, Pinar, Adali, Gupse, Tarik Kani, Haluk, Ozer Demirtas, Coskun, Gunduz, Feyza, Ataizi Celikel, Cigdem, Yilmaz, Yusuf
Publicado 2021

Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture

por Gunduz, Feyza, Aboulnasr, Fatma M, Chandra, Partha K, Hazari, Sidhartha, Poat, Bret, Baker, Darren P, Balart, Luis A, Dash, Srikanta
Publicado 2012

Correction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells

por Poat, Bret, Hazari, Sidhartha, Chandra, Partha K., Gunduz, Feyza, Balart, Luis A., Alvarez, Xavier, Zhang, Yong, Holtzman, Michael J., Dash, Srikanta
Publicado 2010

Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone

por Chandra, Partha K, Hazari, Sidhartha, Poat, Bret, Gunduz, Feyza, Prabhu, Ramesh, Liu, Gerald, Burioni, Roberto, Clementi, Massimo, Garry, Robert F, Dash, Srikanta
Publicado 2010

Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma

por Alan, Aydan Mutis, Alan, Ozkan, Asadov, Ruslan, Demirtas, Coskun Ozer, Kani, Haluk Tarik, Yumuk, Perran Fulden, Ozdogan, Osman Cavit, Baltacioglu, Feyyaz, Gunduz, Feyza
Publicado 2023

Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders

por Demirtas, Coskun Ozer, Ricco, Gabrielle, Ozdogan, Osman Cavit, Baltacioglu, Feyyaz, Ones, Tunc, Yumuk, Perran Fulden, Dulundu, Ender, Uzun, Sinan, Colombatto, Pierro, Oliveri, Filippo, Brunetto, Maurizia Rosanna, Gunduz, Feyza
Publicado 2021

Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index

por Demirtas, Coskun Ozer, Ricco, Gabrielle, Ozdogan, Osman Cavit, Baltacioglu, Feyyaz, Ones, Tunc, Yumuk, Perran Fulden, Dulundu, Ender, Uzun, Sinan, Colombatto, Pierro, Oliveri, Filippo, Brunetto, Maurizia Rosanna, Gunduz, Feyza
Publicado 2022

Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1

por Datta, Sibnarayan, Hazari, Sidhartha, Chandra, Partha K, Samara¹, Maria, Poat, Bret, Gunduz, Feyza, Wimley, William C, Hauser, Hansjorg, Koster, Mario, Lamaze, Christophe, Balart, Luis A, Garry, Robert F, Dash, Srikanta
Publicado 2011

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis

por Chandra, Partha K., Gunduz, Feyza, Hazari, Sidhartha, Kurt, Ramazan, Panigrahi, Rajesh, Poat, Bret, Bruce, David, Cohen, Ari J., Behorquez, Humberto E., Carmody, Ian, Loss, George, Balart, Luis A., Wu, Tong, Dash, Srikanta
Publicado 2014